Clinical Trial Update: Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bortezomib, pomalidomide, and dexamethasone for systemic amyloidosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Jin Lu, MD | Conditions: Systemic Amyloidosis | Phase 2 | Status: RECRUITING